Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ortoma B | ORTB | 27. sep 2024 | 9.20 | +2.22 |
Oscar Properties Holding | OP | 27. sep 2024 | 0.22 | -10.53 |
Oscar Properties Holding Pref | OPPREF | 27. sep 2024 | 155.00 | -7.19 |
Oscar Properties Holding Pref B | OPPREFB | 27. sep 2024 | 1 670.00 | -19.71 |
OssDsign | OSSD | 27. sep 2024 | 6.70 | 0.00 |
OurLiving AB | OURLIV | 27. sep 2024 | 0.29 | 0.00 |
Ovzon | OVZON | 27. sep 2024 | 15.56 | +2.37 |
OX2 | OX2 | 27. sep 2024 | 59.85 | -0.66 |
OXE Marine | OXE | 27. sep 2024 | 0.34 | -8.97 |
Pandox B | PNDXB | 27. sep 2024 | 197.00 | +0.82 |
Paradox Interactive | PDX | 27. sep 2024 | 176.30 | +3.22 |
Paxman | PAX | 27. sep 2024 | 57.40 | -0.69 |
Peab B | PEABB | 27. sep 2024 | 81.15 | -0.86 |
Peptonic Medical | PMED | 27. sep 2024 | 0.01 | +3.23 |
Perpetua Medical B | PERPB | 27. sep 2024 | 4.40 | +2 519.05 |
PetroNor E&P ASA | PNORO | 27. sep 2024 | 8.82 | +0.46 |
PExA | PEXAB | 27. sep 2024 | 0.43 | -0.69 |
PharmaLundensis | PHAL | 27. sep 2024 | 0.50 | -0.60 |
Phase Holographic | PHI | 27. sep 2024 | 4.97 | -3.68 |
Photocat | PCAT | 27. sep 2024 | 10.10 | -0.98 |
Physitrack | PTRK | 27. sep 2024 | 11.95 | 0.00 |
Pierce Group | PIERCE | 27. sep 2024 | 8.10 | +1.25 |
Pila Pharma | PILA | 27. sep 2024 | 5.82 | -1.36 |
PION Group AB | PIONB | 27. sep 2024 | 6.20 | 0.00 |
Pioneer Property Group Pref | PPGO | 27. sep 2024 | 98.80 | 0.00 |
PixelFox | PIXEL | 27. sep 2024 | 0.46 | +6.02 |
Platzer Fastigheter Holding AB (publ) | PLAZB | 27. sep 2024 | 110.20 | +0.92 |
Plejd | PLEJD | 27. sep 2024 | 325.00 | +0.31 |
PMD Device Solutions | PMDS | 27. sep 2024 | 3.50 | +1.74 |
PolarCool | POLAR | 27. sep 2024 | 0.04 | +7.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.